\n\n

OpenAI has quietly listed a new life‑sciences model, gpt‑rosalind‑discovery, on its API pricing page, pricing it the same as the existing gpt‑rosalind‑research model. The entry appeared …

\n\n

Key developments: OpenAI has quietly added a new life‑sciences model, gpt‑rosalind‑discovery, to its API pricing page, positioning it as a dedicated drug‑discovery tool. The model appears …

\n\n

Virtual‑patient simulations are gaining traction as a way to de‑risk expensive human studies. In July, BioinvestGPT used a simulated trial to predict that the experimental drug …